Structure Therapeutics Inc. (GPCR) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q1'22 | Q4'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 1.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -1.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 88.43M | -23.99M | 73.79M | 70.45M | 56.31M | 47.06M | 45.84M | 33.32M | 32.02M | 30.99M | 26.14M | 25.99M | 19.65M | 12.96M | 12.69M | 12.95M | 13.27M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 22.87M | 17.57M | 14.8M | 15.74M | 13.44M | 13.57M | 13.24M | 11.27M | 11.34M | 10.95M | 8.63M | 6.58M | 6.51M | 4.6M | 3.53M | 4.46M | 3.37M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 66.71M | 68.69M | 58.99M | 54.71M | 42.87M | 33.49M | 32.6M | 22.05M | 20.68M | 20.04M | 17.52M | 19.41M | 13.13M | 8.36M | 9.16M | 8.49M | 9.91M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -1000K | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -89.65M | 23.99M | -73.79M | -70.45M | -56.31M | -47.06M | -45.84M | -33.32M | -32.02M | -30.99M | -26.14M | -25.99M | -19.65M | -12.96M | -12.69M | -12.95M | -13.27M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -59.2% | 150.97% | -60.98% | -111.46% | -75.89% | -51.84% | -75.31% | -28.2% | -62.93% | -139.23% | -105.98% | - | - | - | - | - | - |
| EBITDA | -88.43M | 24.4M | -73.5M | -70.16M | -56.04M | -46.79M | -45.57M | -33.08M | -31.79M | -30.92M | -26.07M | -25.91M | -19.58M | -12.88M | -12.62M | -12.88M | -13.21M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -57.8% | 152.15% | -61.28% | -112.07% | -76.26% | -51.31% | -74.83% | -27.67% | -62.38% | -140% | -106.59% | - | - | - | - | - | - |
| D&A (Non-Cash Add-back) | 1.22M | 412K | 291K | 291K | 274K | 273K | 265K | 232K | 222K | 72K | 79K | 74K | 70K | 72K | 76K | 70K | 66K |
| EBIT | -89.65M | 33.17M | -65.6M | -70.45M | -56.31M | -47.06M | -45.84M | -33.32M | -32.02M | -30.99M | -26.14M | -25.99M | -19.65M | -12.96M | -12.69M | -12.95M | -13.27M |
| Net Interest Income | 13.64M | 18.55M | 0 | 8.96M | 9.58M | 10.72M | 0 | 7.33M | 6M | 6.22M | 2.69M | 2.79M | 1.7M | 901K | 349K | -69K | -1K |
| Interest Income | 13.64M | 18.55M | 0 | 8.96M | 9.59M | 10.68M | 0 | 7.33M | 6M | 6.22M | 2.69M | 2.79M | 1.7M | 899.51K | 349K | 0 | 2 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 69K | 1K |
| Other Income/Expense | 13.64M | 9.19M | 8.18M | 8.93M | 9.58M | 10.72M | 11.95M | 7.33M | 6.01M | 6.18M | 2.69M | 2.83M | 1.7M | 901K | 349K | -69K | -1K |
| Pretax Income | -76M | 33.17M | -65.6M | -61.52M | -46.73M | -36.34M | -33.88M | -25.98M | -26.01M | -24.82M | -23.46M | -23.16M | -17.95M | -12.05M | -12.34M | -13.02M | -13.28M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 190.57K | 170K | 108K | 139K | 98K | 136K | 92K | 53K | 29K | -312K | 405K | 118K | 25K | -180K | 73K | 60K | 81K |
| Effective Tax Rate % | -0.25% | 0.51% | -0.16% | -0.23% | -0.21% | -0.37% | -0.27% | -0.2% | -0.11% | 1.26% | -1.73% | -0.51% | -0.14% | 1.49% | -0.59% | -0.46% | -0.61% |
| Net Income | -76.19M | 33M | -65.71M | -61.66M | -46.83M | -36.48M | -33.98M | -26.03M | -26.04M | -24.5M | -23.86M | -23.28M | -17.98M | -10.36M | -12.42M | -13.08M | -15.43M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -62.69% | 190.47% | -93.4% | -136.85% | -79.88% | -48.88% | -42.39% | -11.83% | -44.85% | -136.52% | -92.17% | - | - | - | - | - | - |
| Net Income (Continuing) | -76.19M | 33M | -65.71M | -61.66M | -46.83M | -36.48M | -33.98M | -26.03M | -26.04M | -24.5M | -23.86M | -23.28M | -17.98M | -11.88M | -12.42M | -13.08M | -13.36M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.05 | 0.60 | -1.11 | -1.08 | -0.81 | -0.63 | -0.60 | -0.54 | -0.57 | -0.54 | -0.63 | -0.60 | -0.48 | -0.32 | -1.27 | -0.36 | -0.42 |
| EPS Growth % | -29.63% | 195.24% | -85% | -100% | -42.11% | -16.67% | 4.76% | 10% | -18.75% | -68.75% | 50.39% | - | - | - | - | - | - |
| EPS (Basic) | -1.05 | 0.60 | -1.11 | -1.08 | -0.81 | -0.63 | -0.60 | -0.54 | -0.57 | -0.54 | -0.63 | -0.60 | -0.48 | -0.32 | -1.27 | -0.36 | -0.42 |
| Diluted Shares Outstanding | 72.44M | 59.2M | 58.49M | 57.92M | 57.35M | 57.29M | 57.21M | 49.41M | 46.57M | 46.41M | 38.32M | 38.25M | 37.42M | 36.59M | 39.12M | 36.59M | 36.59M |
| Basic Shares Outstanding | 72.44M | 59.2M | 58.49M | 57.92M | 57.35M | 57.29M | 57.21M | 49.41M | 46.57M | 46.41M | 38.32M | 38.25M | 37.42M | 36.59M | 39.12M | 36.59M | 36.59M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |